微波消融治疗晚期恶性肿瘤

Microwave ablation in the treatment of advanced malignant tumors

目的:CT引导下微波消融(PMAT)技术姑息治疗晚期恶性肿瘤的近期疗效,并探讨其安全性。方法:纳入2017年1月-2019年1月在某院抗肿瘤综合治疗后的晚期实体瘤患者67例,在CT引导下实施PMAT术1~5次,总共达到104例次治疗,随访以评估癌性疼痛痛控制、生活质量改善等近期疗效以及副反应的发生。一年、两年生存率评估远期疗效。结果:67例患者共130枚病灶开展了PMAT治疗104例次,成功率100.0%。1个月患者的体力改善率95.52%(64/67),3个月行CT检查,评估总有效率79.23%(53/67)。1年生存率达到80.60%(54/67),2年生存率71.43%(20/28)。术中主要不良反应为疼痛,未影响治疗完成;术后常见有发热、气胸、少量胸腹腔积液、肺炎,未出现严重并发症。结论:PMAT治疗晚期恶性肿瘤操作方便,患者的并发症轻、少,近期疗效好,对晚期患者来说是一种值得尝试的姑息治疗方法。

Objective:To investigate the efficacy of CT-guided(MA)in palliative treatment of beneficial swelling and fat during call period,and to explore its safety.Method:in 67 patients with solid tumor after comprehensive treatment of arsine tumor from January 2017 to January 2019.under the guidance of CT,67 patients with solid tumor were treated with lantern once or five times,and a total of104 cases were treated to evaluate the occurrence of near-stage therapeutic candle and side effect,such as circular herbal disease,thinning of quality of life and so on,and the occurrence of side effects was evaluated.Rusult:One year,the long-term survival rate of 67 patients was evaluated by PMAT.The physical improvement rate of the patients was 95.52%(64/67).The total effective case was evaluated by cT examination on the90th day.The total effective case was evaluated by79.23%(53/67)and1 year survival rate 80.60%(54/67).2 year survival rate 71.43(20/28).The main adverse reactions were British pain,fever,qi,less lumen fluid accumulation and pneumonia.No serious complications occurred.Conclusion:The PMAT is convenient for the operation of the advanced malignant tumor,the complication of the patient is light,the short-term curative effect is good.